Delivery Order SPE2DB20D3303-SPE2DB24FY6C3
Award Date
12/28/23
Potential Completion Date
12/29/23
Potential Value
$6.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication, valued at $1,102.08. The award was made by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The contract has a ceiling value of $1,102.08 and is a delivery order under an Indefinite Delivery Contract (IDC) held...
This federal contract award is for the delivery of Spiriva Respimat 2.5 mcg inhalers to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $7,112.62. The contract has a firm fixed price and is set to be completed by April 25, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication, with a total ceiling value of $2,154.16. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
This federal contract award is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication, with a ceiling value of $7,669.16. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 22, 2024, with a delivery order contract type and firm fixed pricing. The contract has an ultimate completion date of August 23, 2024 and was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a significant customer of Amerisourcebergen. This...
This federal contract award is for the delivery of Spiriva Respimat 1.25 mcg inhalation solution to the Defense Logistics Agency (DLA). The contract has a value of $1,488.72 and a completion date of May 1, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication, to the Defense Logistics Agency (DLA). The award, valued at $2,287.89, was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a Firm Fixed Price Delivery Order contract valued at $1,275.44, with a period of performance through February 5, 2024. The contract was awarded on February 2, 2024 and does not have a set-aside designation, indicating it was awarded through full and open competition....
This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 5, 2024, with a ceiling value of $2,176.55 and a completion date of December 6, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Spiriva Respimat 2.5 mcg inhalers. The $3,578.37 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that supports U.S. military healthcare. The contract has an ultimate completion date of September 14, 2022 and was awarded on September 13, 2022. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a...
This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $3,223.51 and is a Firm Fixed Price Delivery Order. It has an ultimate completion date of October 30, 2023. Amerisourcebergen Drug Corp holds...